Is scleroderma an autoantibody mediated disease?

Current Opinion in Rheumatology

Volumn 18, Issue 6, 2006, Pages 579-581

  Arnett, Frank C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Autoantibodies; Endothelial cells; Fibrillin; Matrix metalloproteinases; Platelet derived growth factor; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; ENDOTHELIAL CELL ANTIBODY; FIBRILLIN 1 ANTIBODY; INTERSTITIAL COLLAGENASE ANTIBODY; PLATELET DERIVED GROWTH FACTOR BETA ANTIBODY; STROMELYSIN ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNE DISEASE; BLOOD VESSEL INJURY; ENDOTHELIUM CELL; FIBROBLAST; FIBROSIS; HUMAN; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; AUTOIMMUNITY; ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MICROFILAMENT PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 33750207136     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000245726.33006.c3     Document Type: Review

References (12)

1. Arnett FC. HLA and autoimmunity in scleroderma (systemic sclerosis). In: Korn JH, LeRoy EC, editors. Immuno-pathogenesis of scleroderma. Internat Rev Immunol 1995; 12:107-128.
2. Cepeda EJ, Reveille JD. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 2004; 16:723-732.
3. Bordron A, Dueymes M, Levy Y, et al. The binding of some human antiendothelial cell antibodies induces endothelial apoptosis. J Clin Invest 1996; 101:2029-2035.
4. Ahmed SS, Tan FK, Arnett FC, et al. Scleroderma sera containing endothelial cell antibodies induce apoptosis and fibrillin-1 in human dermal endothelial cells. Arthritis Rheum 2006; 54:2250-2262.
5. Lunardi C, Bason C, Navone R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6:1183-1186.
6. Tan FK, Arnett FC, Reveille JD, et al. Autoantibodies to fibrillin-1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLAalleles. Arthritis Rheum2000; 43:2464-2471.
7. Zhou X, Tan FK, Wallis D, et al. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF beta pathway and recapitulate the 'scleroderma phenotype'. J Immunol 2005; 175:4555-4560.
8. Sato S, Hayakawa I, Hasegawa M, et al. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 2003; 120:542-547.
9. Nishijima C, Hayakawa I, Matsushita T, Komura K, et al. Autoantibody against matrix metalloproteinase-3 patients with systemic sclerosis. Clin Exp Immunol 2004; 138:357-363.
10. Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354:2667-2676.
11. Tan FK. Autoantibodies against PDGF receptor in scleroderma [editorial]. N Engl J Med 2006; 354:2709-2711.
12. Sisto M, Lisi S, Castellana D, Scagliusi P, et al. Autoantibodies from Sjogren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 2006; June 20 [Epub ahead of print]